Kinaset Therapeutics
Kinaset Therapeutics is a biotechnology company that develops precision medicines targeting kinase-driven diseases through selective inhibition strategies aimed at improving therapeutic profiles and addressing unmet clinical needs. Its pipeline focuses on small molecule inhibitors designed to modulate specific signalling pathways implicated in inflammatory, immune-mediated, and proliferative disorders by targeting distinct kinase enzymes with tailored selectivity. The company combines medicinal chemistry, structure-based design, and translational research to optimize compounds for efficacy, safety, and pharmacokinetic properties that support clinical evaluation. Kinaset Therapeutics collaborates with research institutions and industry partners to advance its programs and validate mechanisms of action in relevant disease models. Its development efforts prioritize therapeutic candidates that may offer differentiated treatment options for conditions driven by dysregulated kinase activity.
Domain
kinasettherapeutics.com
Country
United StatesIndustry
Health CareEmployees
1-10
Last Funding
$103.0M
Founded
2019
Tech Stack (11 technologies)
Frequently Asked Questions
What technologies does Kinaset Therapeutics use?+
Kinaset Therapeutics uses 11 technologies including Adobe Fonts, Squarespace, Squarespace Commerce.
What industry is Kinaset Therapeutics in?+
Kinaset Therapeutics operates in the Health Care industry.
Where is Kinaset Therapeutics based?+
Kinaset Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026